Initiation of the Phase 2 EMPOWER trial of ARD-201 for the treatment of obesity and obesity-related conditions as a fixed-dose combination of ARD-101 with a dipeptidyl peptidase-4 (DPP-4) inhibitor is ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

("Rani Therapeutics” or "Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of ...

Mick Hitchcock, Ph.D., appointed Interim Chief Executive OfficerBiomea preparing icovamenib for late-stage clinical developmentMultiple milestones anticipated in 2025 including:FDA meeting anticipated ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

Consuming sucralose, a popular sugar substitute, could alter your brain activity to increase your appetite, a new study found ...

A research team has uncovered higher rates of heart disease and worse heart health affecting adults living in rural ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Mental health and weight are deeply connected. Discover how stress, trauma, and emotions impact your body and what to do ...

A new small study finds that certain nutritional choices may be a way to keep biological age low and even reverse it.

Whether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid hearing about the sudden ...